PokerKing¡¤(ÖйúÓÎ)ÓÐÏÞPokerKing¹ÙÍøË¾¹ÙÍø



Li Peishang was invited to attend the Vascular Diseases Translational Medicine Expansion Platform

2023-04-17 17:41

On April 16, the theme event "Trends, Pain Points and Countermeasures of the transformation of medical scientific and technological Achievements", sponsored by the Vascular Diseases Translational Medicine Expansion Platform of Beijing Chaoyang District Science and Technology Plan and undertaken by the First Affiliated Hospital of Tsinghua University, was held in Beijing.

Li Peishang, chairman and CEO of Mednovo Group Co., Ltd, was invited to attend the event and gave a speech entitled "Channel Victory, Innovation and Stability", shared the development of the group in recent years, and made suggestions for the transformation of medical scientific and technological achievements from the marketing strategy.


ͼƬ


At present, innovation and transformation in the medical field have attracted much attention. How can we help solve the pain point of scientific research results from "productization" to "commercialization"?


ͼƬ


Dealers are the closest workers to the clinic and the market. Li Peishang pointed out that on the one hand, dealers can combine with first-line clinicians to tap clinical needs and solve problems such as upstream and downstream information asymmetry; On the other hand, dealers can also help innovate, transform, screen patents, evaluate products, investigate the clinical value of products, etc., and provide suggestions for product development from the perspective of the market.


ͼƬ



At present, Mednovo has gradually entered the field of research and development and production after upgrading within the industry. Li Peishang said that Mednovo will continue to focus on people's lives and health, further strengthen the research and transformation of innovative technologies, focus on research and development and provide safe, effective and inclusive medical products and services, and promote the leap forward of the medical and health industry with technological innovation, and effectively contribute to the transformation of medical innovation.

The event also invited leaders of supervision and incubation departments related to transformation in the field of vascular medicine, first-line vascular medical staff from the First Affiliated Hospital of Tsinghua University, China-Japan Friendship Hospital, Beijing Anzhen Hospital affiliated to Capital Medical University, etc. Medical researchers from Tsinghua University and Beijing Institute of Technology, as well as venture capital practitioners in the field of medical health, technical and management experts from R&D, production and marketing institutions, etc., discussed the topic in depth.

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿